Macrobid vs. Zithromax

See how Macrobid and Zithromax compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Macrobid only treats urinary tract infections, while Zithromax covers a much wider range of bacterial infections throughout the body.

  • Macrobid is taken twice daily for a full week, whereas Zithromax often works as a single dose or a short 5-day course.

  • Zithromax carries an FDA warning for heart rhythm changes that Macrobid does not, but Macrobid is unsafe for anyone with reduced kidney function.

Macrobid vs. Zithromax Drug Summary

Macrobid

Macrobid is a nitrofuran antibiotic that treats uncomplicated urinary tract infections caused by susceptible bacteria like E. coli. It is taken as an oral capsule, usually 100 mg every 12 hours for seven days. It concentrates in urine rather than the bloodstream, so it is not used for infections outside the urinary tract.

Zithromax

Zithromax is a macrolide antibiotic used for a wide range of bacterial infections, including pneumonia, bronchitis, sinusitis, and certain sexually transmitted infections. It comes as a tablet, liquid, or IV formulation, often given as a short 5-day course or a single dose. Its long tissue half-life lets it clear infections after just a few doses.

Macrobid vs. Zithromax Side Effects

Macrobid

Most common
Nausea (up to 8%)
Headache (up to 6%)
Flatulence (up to 1.5%)

Zithromax

Most common
Vomiting (up to 7%)
Diarrhea (5% to 14%)
Nausea (3% to 18%)

Macrobid vs. Zithromax Dosage

Macrobid

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 100 mg every 12 hours Days 1-7
Maximum dose 100 mg every 12 hours Same as starting
Dose changes None Fixed dose

Zithromax

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 500 mg once daily Day 1
Maximum dose 30 mg/kg single dose If needed
Dose changes 5 increases As tolerated

Macrobid vs. Zithromax Indications

Macrobid

Macrobid is FDA-approved only for treating acute, uncomplicated urinary tract infections caused by susceptible strains of E. coli or S. saprophyticus. Doctors also prescribe it off-label at low doses for long-term prevention of recurrent UTIs. It is not approved for kidney infections or for use in young children.

  • Acute uncomplicated UTI (cystitis)

  • Caused by E. coli or S. saprophyticus

  • Off-label: recurrent UTI prevention

  • Not for pyelonephritis or kidney infections

Zithromax

Zithromax is FDA-approved for a broad set of bacterial infections, including bronchitis, pneumonia, sinusitis, ear infections, skin infections, and certain sexually transmitted infections. It is also approved to prevent and treat disseminated MAC disease in people with weakened immune systems. Off-label, it is sometimes used for traveler's diarrhea and eye infections.

  • Community-acquired pneumonia

  • Acute bronchitis and sinusitis

  • Chlamydia and gonorrhea infections

  • MAC disease prevention and treatment

Macrobid vs. Zithromax Pros and Cons

Macrobid

Macrobid remains a dependable, narrow-spectrum option for uncomplicated UTIs, largely because bacterial resistance to it has stayed low despite decades of use. It is not an option for anyone with reduced kidney function, and its coverage is limited strictly to the urinary tract.

Pros

  • Reliable long-term effectiveness against E. coli despite decades of use

  • Stays concentrated in urine, so it disrupts gut bacteria less than broader antibiotics

  • No cardiac rhythm warnings on the label

  • Straightforward course without repeated redosing

Cons

  • Cannot be used with reduced kidney function (CrCl under 60 mL/min)

  • Rare but serious risk of lung and liver toxicity with long-term use

  • Not effective for infections outside the urinary tract

  • Requires twice-daily dosing for a full week

Zithromax

Zithromax's broad spectrum and short dosing courses make it convenient for many common respiratory, skin, and sexually transmitted infections. Its heart rhythm warning and rising resistance rates are important trade-offs to weigh against that convenience.

Pros

  • Treats infections throughout the body, not just one organ system

  • Some regimens finish in a single dose or within 5 days

  • Long tissue half-life means fewer doses are needed overall

  • Also used to prevent serious MAC infections in immunocompromised patients

Cons

  • Carries an FDA warning for QT prolongation and heart rhythm risk

  • Growing bacterial resistance has reduced reliability for some infections

  • More gastrointestinal side effects reported, including diarrhea and vomiting

  • Not appropriate for viral infections despite common misuse

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.